Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 58
Filter
1.
Biotechnol Lett ; 43(7): 1289-1301, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33864523

ABSTRACT

OBJECTIVES: To establish reliable methods for the extraction and quantification of the total carbohydrate and intracellular saccharides from Mortierella alpina and study the changes between carbohydrate and lipid in fermentation process. RESULTS: The extraction of mycelia with HCl following a photometric phenol-sulphuric acid reaction was identified as an optimal method for total carbohydrate analysis in Mortierella alpina, which the extraction efficiency performed 1.1-3.6 fold than other five methods. The total carbohydrate content increased from initial 19.26 to 25.86% during early fermentation process and declined gradually thereafter, while the fatty acid was increasing from 8.47 to 31.03%. For separation and qualitative estimation of intracellular saccharides, the acetonitrile/water freeze-thaw method for extraction and Sugar-Pak I column for separation proved to be possible. With the glucose rapidly decreasing at the beginning of growth, the trehalose accumulated rapidly from 1.63 to 5.04% and then decreased slightly but maintain above 4% of dry biomass. CONCLUSIONS: This work established comprehensive carbohydrate extraction and analysis methods of Mortierella alpina and identified the main saccharide in fermentation process which indicated that the accumulation of fatty acids was related to the change of intracellular carbohydrate content.


Subject(s)
Carbohydrates/analysis , Lipids/analysis , Mortierella/chemistry , Carbohydrates/chemistry , Chromatography, High Pressure Liquid/instrumentation , Colorimetry , Fatty Acids/isolation & purification , Fermentation , Glucose/isolation & purification , Lipids/chemistry , Photometry , Trehalose/isolation & purification
2.
Bull Exp Biol Med ; 169(4): 474-477, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32910375

ABSTRACT

The biosurfactant monoacyltrehalose fraction isolated from Rhodococcus ruber IEGM 231 actinobacterium suppresses antibody production, bactericidal potential, and production of IL-1ß by mouse peritoneal cells after intraperitoneal and intramuscular injection and stimulates the production of IL-10 after intraperitoneal injection. The data of in vitro experiments attest to an important role of bacterial glycolipids in the regulation of the functions of splenocytes and peritoneal macrophages.


Subject(s)
Immunologic Factors/pharmacology , Lymphocytes/drug effects , Macrophages, Peritoneal/drug effects , Rhodococcus/chemistry , Surface-Active Agents/pharmacology , Trehalose/pharmacology , Adaptive Immunity/drug effects , Animals , Antibodies, Bacterial/biosynthesis , Gene Expression , Immunity, Innate/drug effects , Immunologic Factors/chemistry , Immunologic Factors/isolation & purification , Injections, Intraperitoneal , Interleukin-10/genetics , Interleukin-10/immunology , Interleukin-1beta/genetics , Interleukin-1beta/immunology , Lymphocytes/cytology , Lymphocytes/immunology , Macrophages, Peritoneal/cytology , Macrophages, Peritoneal/immunology , Male , Mice , Primary Cell Culture , Spleen/cytology , Spleen/drug effects , Spleen/immunology , Surface-Active Agents/chemistry , Surface-Active Agents/isolation & purification , Trehalose/analogs & derivatives , Trehalose/isolation & purification
3.
Sci Rep ; 10(1): 13850, 2020 08 14.
Article in English | MEDLINE | ID: mdl-32796903

ABSTRACT

We report on a potential method to separate sugars by using the specific interaction between fullerenes and saccharides in liquid chromatography (LC). Aromatic rings with high electron density are believed to interact strongly with saccharides due to CH-π and/or OH-π interactions. In this study, the fullerene-bonded columns were used to separate saccharides by LC under aqueous conditions. As a result, 2-aminobenzamide-labeled glucose homopolymer (Glcs) was effectively separated by both C60 and C70 columns in the range of Glc-1 to Glc-20 and high blood glucose level being retained in greater quantity. Furthermore, similar separations were identified by LC-mass spectrometry with non-labeled glucose homopolymers. Theoretical study based on molecular dynamics and DFT calculation demonstrated that a supramolecular complex of saccharide-fullerene was formed through CH-π and/or OH-π interactions, and that the interactions between saccharide and fullerene increase with the increase units of the saccharide. Additionally, the C60 column retained disaccharides containing maltose, trehalose, and sucrose. In this case, it was assumed that the retention rates were determined by the difference of the dipole moment in each saccharide. These results suggest that the dipole-induced dipole interaction was dominant, and that maltose-with the higher dipole moment-was more strongly retained compared to other disaccharides having lower dipole moment.


Subject(s)
Glucaric Acid/isolation & purification , Maltose/isolation & purification , Silicon Dioxide/chemistry , Sucrose/isolation & purification , Trehalose/isolation & purification , Chromatography, Liquid/methods , Computer Simulation , Mass Spectrometry/methods
4.
ACS Chem Biol ; 15(7): 1835-1841, 2020 07 17.
Article in English | MEDLINE | ID: mdl-32293864

ABSTRACT

The first asymmetric total synthesis of three structures proposed for mycobacterial diacyl trehaloses, DAT1, DAT2, and DAT3 is reported. The presence of two of these glycolipids, DAT1 and DAT3, within different strains of pathogenic M. tuberculosis was confirmed, and it was shown that their abundance varies significantly. In mass spectrometry, synthetic DAT2 possessed almost identical fragmentation patterns to presumptive DAT2 from Mycobacterium tuberculosis H37Rv, but did not coelute by HPLC, raising questions as the precise relationship of the synthetic and natural materials. The synthetic DATs were examined as agonists for signaling by the C-type lectin, Mincle. The small differences in the chemical structure of the lipidic parts of DAT1, DAT2, and DAT3 led to drastic differences of Mincle binding and activation, with DAT3 showing similar potency as the known Mincle agonist trehalose dimycolate (TDM). In the future, DAT3 could serve as basis for the design of vaccine adjuvants with simplified chemical structure.


Subject(s)
Glycolipids/pharmacology , Lectins, C-Type/agonists , Membrane Proteins/agonists , Receptors, Immunologic/agonists , Trehalose/analogs & derivatives , Trehalose/pharmacology , Animals , Chromatography, Liquid , Glycolipids/chemical synthesis , Glycolipids/isolation & purification , Humans , Mass Spectrometry , Mice , Molecular Structure , Mycobacterium tuberculosis/chemistry , Protein Binding , Stereoisomerism , Trehalose/isolation & purification
5.
Chem Biodivers ; 16(9): e1900353, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31329336

ABSTRACT

Five known secondary metabolites, chrysophanol (1), 7,7'-biphyscion (2), secalonic acid D (3), mannitol (4) and trehalose (5) were isolated for the first time from the extracts of the fungus Phialomyces macrosporus. Their structures were elucidated by NMR methods (1D and 2D NMR analysis), optical activity and ESI-MS. Complete 1 H and 13 C assignments were performed for compound 2. The antimicrobial activity was evaluated by serial microdilution assay for compounds 2 and 3 and results showed that compound 3 exhibited a significant growth inhibition at concentrations of 15.6 mg/ml (S. aureus and S. choleraesius) and 0.97 mg/mL (B. subtilis), comparable to the positive control.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacillus subtilis/drug effects , Salmonella/drug effects , Staphylococcus aureus/drug effects , Anthraquinones/chemistry , Anthraquinones/isolation & purification , Anthraquinones/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Bacillus subtilis/growth & development , Dose-Response Relationship, Drug , Magnetic Resonance Spectroscopy , Mannitol/chemistry , Mannitol/isolation & purification , Mannitol/pharmacology , Microbial Sensitivity Tests , Molecular Structure , Salmonella/growth & development , Staphylococcus aureus/growth & development , Trehalose/chemistry , Trehalose/isolation & purification , Trehalose/pharmacology , Xanthones/chemistry , Xanthones/isolation & purification , Xanthones/pharmacology
6.
Enzyme Microb Technol ; 113: 83-90, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29602391

ABSTRACT

The process for production of trehalose using trehalose synthase (TreS) to convert maltose into trehalose in one step is highly desirable in the industry. Nonetheless, the studies on industrial-scale production of trehalose by recombinant TreS in Escherichia coli are still scarce. In this study, a TreS from Pseudomonas putida ATCC47054 was expressed in E. coli BL21(DE3) via plasmids pET15b and pET22b. pET15b-treS showed better plasmid stability and TreS expression, which revealed that the highest activity, 39866±1420U/(g dry cell weight) at the final lactose concentration of 4g/L for 7h at 27°C in a 5-L fermentor at pH 8.0. The use of 30% (w/v) high-maltose syrup as a substrate can extend the temperature tolerance of TreS to 60°C. More than 64% of maltose can be converted into trehalose by adding 200U of TreS per gram of maltose at 50°C for 24h. The total sugar content of the trehalose syrup reached 95.0%±1.0% (w/w) after separation. The recovery rate of trehalose dehydrate reached 57.0%±2.0% after slow cooling, and the purity was 99.0±0.2%. Our study revealed a safe and reliable process of trehalose production by recombinant TreS.


Subject(s)
Escherichia coli/enzymology , Glucosyltransferases/metabolism , Pseudomonas putida/enzymology , Recombinant Proteins/metabolism , Trehalose/isolation & purification , Trehalose/metabolism , Biocatalysis , Escherichia coli/genetics , Escherichia coli/growth & development , Fermentation , Glucosyltransferases/genetics , Maltose/metabolism , Pseudomonas putida/genetics , Pseudomonas putida/growth & development , Recombinant Proteins/genetics
7.
Metab Eng ; 39: 1-8, 2017 01.
Article in English | MEDLINE | ID: mdl-27818152

ABSTRACT

In nature glucose is a common carbon and energy source for catabolic use and also a building unit of polysaccharides and glycosylated compounds. The presence of strong glucose catabolic pathways in microorganism rapidly decomposes glucose into smaller metabolites and challenges non-catabolic utilization of glucose as C6 building unit or precursor. To address this dilemma, we design a synergetic carbon utilization mechanism (SynCar), in which glucose catabolism is inactivated and a second carbon source (e.g. glycerol) is employed to maintain cell growth and rationally strengthen PEP driving force for glucose uptake and non-catabolic utilization. Remarkably, a trehalose biosynthesis model developed for proof-of-concept indicates that SynCar leads to 131% and 200% improvement in trehalose titer and yield, respectively. The conversion rate of glucose to trehalose reaches 91% of the theoretical maximum. This work demonstrates the broad applicability of SynCar in the biosynthesis of molecules derived from non-catabolic glucose.


Subject(s)
Carbon/metabolism , Escherichia coli Proteins/metabolism , Escherichia coli/physiology , Glucose/metabolism , Metabolic Engineering/methods , Models, Biological , Trehalose/biosynthesis , Biosynthetic Pathways/physiology , Cell Proliferation/physiology , Computer Simulation , Escherichia coli Proteins/genetics , Glucose/genetics , Glycerol/metabolism , Metabolic Flux Analysis/methods , Metabolic Networks and Pathways/physiology , Metabolism/physiology , Trehalose/genetics , Trehalose/isolation & purification
8.
Z Naturforsch C J Biosci ; 71(3-4): 87-92, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26985685

ABSTRACT

In this study, the effect of Mougeotia nummuloides and Spirulina major on Vero cells (African green monkey kidney), C6 cells (rat brain tumor cells) and HeLa cells (human uterus carcinoma) was investigated in vitro. The antiproliferative effect of the methanol extract of M. nummuloides and S. major compared with 5-fluorourasil (5-FU) and cisplatin was tested at various concentrations using the BrdU Cell Proliferation ELISA. Both M. nummuloides and S. major extracts significantly inhibited the proliferation of Vero, HeLa and C6 cancer cell lines with IC50 and IC75 values. The M. nummuloides extract exhibited higher activity than 5-FU and cisplatin on Vero and C6 cells at high concentrations. The S. major extract revealed better antifproliferative activity than standards against Vero cells at 500 µg/mL. The compounds of methanol extracts were determined by GC-MS after the silylation process. Trehalose, monostearin and 1-monopalmitin were detected as major products in the M. nummuloides extract where as in the S. major extract; monostearin, 1-monopalmitin and hexyl alcohol were the main constituents.


Subject(s)
Biological Products/pharmacology , Cell Proliferation/drug effects , Mougeotia/chemistry , Spirulina/chemistry , Animals , Biological Products/chemistry , Biological Products/isolation & purification , Cell Line, Tumor , Cells, Cultured , Chlorocebus aethiops , Gas Chromatography-Mass Spectrometry , Glycerides/chemistry , Glycerides/isolation & purification , Glycerides/pharmacology , HeLa Cells , Humans , Inhibitory Concentration 50 , Methanol/chemistry , Molecular Structure , Mougeotia/cytology , Neoplasms/pathology , Rats , Spirulina/cytology , Trehalose/chemistry , Trehalose/isolation & purification , Trehalose/pharmacology , Vero Cells
9.
BMC Immunol ; 16: 38, 2015 Jun 23.
Article in English | MEDLINE | ID: mdl-26100760

ABSTRACT

BACKGROUND: Tuberculosis (TB) remains a serious human health problem that affects millions of people in the world. Understanding the biology of Mycobacterium tuberculosis (Mtb) is essential for tackling this devastating disease. Mtb possesses a very complex cell envelope containing a variety of lipid components that participate in the establishment of the infection. We have previously demonstrated that di-O-acylated trehalose (DAT), a non-covalently linked cell wall glycolipid, inhibits the proliferation of T lymphocytes and the production of cytokines. RESULTS: In this work we show that DAT and the closely related tri-O-acylated trehalose (TAT) inhibits nitric oxide (NO) production and the inducible nitric oxide synthase (iNOS) expression in macrophages (MØ). CONCLUSIONS: These findings show that DAT and TAT are cell-wall located virulence factors that downregulate an important effector of the immune response against mycobacteria.


Subject(s)
Glycolipids/pharmacology , Macrophages/enzymology , Mycobacterium/chemistry , Nitric Oxide Synthase Type II/metabolism , Nitric Oxide/biosynthesis , Trehalose/pharmacology , Acylation/drug effects , Animals , Bone Marrow Cells/cytology , Bone Marrow Cells/drug effects , Bone Marrow Cells/metabolism , Down-Regulation/drug effects , Glycolipids/isolation & purification , Interferon-gamma/pharmacology , Lipopolysaccharides/pharmacology , Macrophages/drug effects , Mice, Inbred BALB C , Trehalose/isolation & purification
10.
Carbohydr Res ; 411: 49-55, 2015 Jun 26.
Article in English | MEDLINE | ID: mdl-25974853

ABSTRACT

Different fungi, including the genera Neosartorya, Byssochlamys and Talaromyces, produce (asco)spores that survive pasteurization treatments and are regarded as the most stress-resistant eukaryotic cells. Here, the NMR analysis of a series of trehalose-based oligosaccharides, being compatible solutes that are accumulated to high levels in ascospores of the fungus Neosartorya fischeri, is presented. These oligosaccharides consist of an α,α-trehalose backbone, extended with one [α-D-Glcp-(1 → 6)-α-D-Glcp-(1 ↔ 1)-α-D-Glcp; isobemisiose], two [α-D-Glcp-(1 → 6)-α-D-Glcp-(1 → 6)-α-D-Glcp-(1 ↔ 1)-α-D-Glcp] or three [α-D-Glcp-(1 → 6)-α-D-Glcp-(1 → 6)-α-D-Glcp-(1 → 6)-α-D-Glcp-(1 ↔ 1)-α-D-Glcp] glucose units. The tetra- and pentasaccharide, dubbed neosartose and fischerose, respectively, have not been reported before to occur in nature.


Subject(s)
Aspergillus/chemistry , Fungal Polysaccharides/chemistry , Spores, Fungal/chemistry , Trehalose/chemistry , Aspergillus/physiology , Carbohydrate Conformation , Carbohydrate Sequence , Chromatography, Gel , Fungal Polysaccharides/isolation & purification , Molecular Sequence Data , Trehalose/isolation & purification
11.
J Proteome Res ; 14(5): 2331-47, 2015 May 01.
Article in English | MEDLINE | ID: mdl-25825269

ABSTRACT

Silkworm (Bombyx mori) is a lepidopteran-holometabolic model organism. To understand its developmental biochemistry, we characterized the larval hemolymph metabonome from the third instar to prepupa stage using (1)H NMR spectroscopy whilst hemolymph fatty acid composition using GC-FID/MS. We unambiguously assigned more than 60 metabolites, among which tyrosine-o-ß-glucuronide, mesaconate, homocarnosine, and picolinate were reported for the first time from the silkworm hemolymph. Phosphorylcholine was the most abundant metabolite in all developmental stages with exception for the periods before the third and fourth molting. We also found obvious developmental dependence for the hemolymph metabonome involving multiple pathways including protein biosyntheses, glycolysis, TCA cycle, the metabolisms of choline amino acids, fatty acids, purines, and pyrimidines. Most hemolymph amino acids had two elevations during the feeding period of the fourth instar and prepupa stage. Trehalose was the major blood sugar before day 8 of the fifth instar, whereas glucose became the major blood sugar after spinning. C16:0, C18:0 and its unsaturated forms were dominant fatty acids in hemolymph. The developmental changes of hemolymph metabonome were associated with dietary nutrient intakes, biosyntheses of cell membrane, pigments, proteins, and energy metabolism. These findings offered essential biochemistry information in terms of the dynamic metabolic changes during silkworm development.


Subject(s)
Bombyx/chemistry , Hemolymph/chemistry , Insect Proteins/isolation & purification , Metabolome , Animals , Bombyx/growth & development , Fatty Acids/isolation & purification , Fatty Acids/metabolism , Gas Chromatography-Mass Spectrometry , Glucose/isolation & purification , Glucose/metabolism , Insect Proteins/metabolism , Larva/chemistry , Larva/growth & development , Metabolic Networks and Pathways/physiology , Molting/physiology , Nuclear Magnetic Resonance, Biomolecular , Phosphorylcholine/isolation & purification , Phosphorylcholine/metabolism , Pupa/chemistry , Pupa/growth & development , Trehalose/isolation & purification , Trehalose/metabolism , Zygote/chemistry , Zygote/growth & development
12.
J Sep Sci ; 38(13): 2229-37, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25873564

ABSTRACT

Trehalose, a nonreducing disaccharide, has been extensively applied to food, cosmetics, and pharmaceutical goods. The resultant solution of trehalose prepared by enzymatic methods includes high amounts of maltose. However, it is quite difficult to separate maltose and trehalose on an industrial scale because of their similar properties. In this paper, a high-performance resin was selected as a stationary phase to separate trehalose and maltose, and the resolution of these sugars was 0.59. The potential of a cation exchange resin was investigated as the stationary phase in separating trehalose and maltose using deionized water as the mobile phase. Based on the equilibrium dispersive model, the axial dispersion coefficients and overall mass transfer coefficients of maltose and trehalose were determined by moment analysis at two different temperatures, 50 and 70°C. Other parameters, including the column void and the adsorption isotherms, were also determined and applied to simulate the elution curves of trehalose and maltose. The simulated results matched the experimental data, validating the parameters. The optimized parameters are critical to the chromatographic separation of trehalose and maltose on an industrial scale.


Subject(s)
Chromatography, High Pressure Liquid/methods , Maltose/isolation & purification , Trehalose/isolation & purification , Adsorption , Hot Temperature , Kinetics , Porosity , Thermodynamics
13.
J Antibiot (Tokyo) ; 68(8): 521-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25757606

ABSTRACT

Trehalose has widespread use as a sweetener, humectant and stabilizer, and is now attracting attention as a promising candidate for the treatment of neurodegenerative diseases as it is an autophagy inducer and chemical chaperone. However, the bioavailability of trehalose is low because it is digested by the hydrolyzing enzyme trehalase, expressed in the intestine and kidney. Enzyme-stable analogs of trehalose would potentially solve this problem. We have previously reported an enzyme-stable analog of trehalose, lentztrehalose, and herein report two new analogs. The original lentztrehalose has been renamed lentztrehalose A and the analogs named lentztrehaloses B and C. Lentztrehalose B is a di-dehydroxylated analog and lentztrehalose C is a cyclized analog of lentztrehalose A. All the lentztrehaloses are only minimally hydrolyzed by mammalian trehalase. The production of the lentztrehaloses is high in rather dry conditions and low in wet conditions. Lentztrehalose B shows a moderate antioxidative activity. These facts suggest that the lentztrehaloses are produced as humectants or protectants for the producer microorganism under severe environmental conditions. All the lentztrehaloses induce autophagy in human cancer cells at a comparable level to trehalose. Considering the enzyme-stability, these lentztrehaloses can be regarded as promising new drug candidates for the treatment of neurodegenerative diseases and other autophagy-related diseases, such as diabetes, arteriosclerosis, cancer and heart disease.


Subject(s)
Autophagy/drug effects , Trehalose/analogs & derivatives , Cell Line, Tumor , Cell Survival/drug effects , Drug Stability , Humans , Hydrolysis , Molecular Structure , Trehalase/metabolism , Trehalose/chemistry , Trehalose/isolation & purification , Trehalose/metabolism
14.
J Microbiol Biotechnol ; 25(4): 439-47, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25370728

ABSTRACT

The objective of this study was to isolate and identify the chemical structure of a biosurfactant produced by Nocardia farcinica strain BN26 isolated from soil, and evaluate its in vitro antitumor activity on a panel of human cancer cell lines. Strain BN26 was found to produce glycolipid biosurfactant on n-hexadecane as the sole carbon source. The biosurfactant was purified using medium-pressure liquid chromatography and characterized as trehalose lipid tetraester (THL) by nuclear magnetic resonance spectroscopy and mass spectrometry. Subsequently, the cytotoxic effects of THL on cancer cell lines BV-173, KE-37 (SKW-3), HL-60, HL-60/DOX, and JMSU-1 were evaluated by MTT assay. It was shown that THL exerted concentration-dependent antiproliferative activity against the human tumor cell lines and mediated cell death by the induction of partial oligonucleosomal DNA fragmentation. These findings suggest that THL could be of potential to apply in biomedicine as a therapeutic agent.


Subject(s)
Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Nocardia/metabolism , Surface-Active Agents/chemistry , Surface-Active Agents/pharmacology , Trehalose/chemistry , Trehalose/pharmacology , Adult , Aged , Antineoplastic Agents/isolation & purification , Apoptosis/drug effects , Cell Line, Tumor , Dose-Response Relationship, Drug , Female , Humans , Inhibitory Concentration 50 , Lymphocytes/drug effects , Male , Middle Aged , Molecular Structure , Nocardia/classification , Nocardia/genetics , Nocardia/isolation & purification , Proton Magnetic Resonance Spectroscopy , Soil Microbiology , Surface-Active Agents/isolation & purification , Trehalose/isolation & purification
15.
Appl Microbiol Biotechnol ; 98(21): 8905-15, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25091045

ABSTRACT

Actinomycetales are known to produce various secondary metabolites including products with surface-active and emulsifying properties known as biosurfactants. In this study, the nonpathogenic actinomycetes Tsukamurella spumae and Tsukamurella pseudospumae are described as producers of extracellular trehalose lipid biosurfactants when grown on sunflower oil or its main component glyceryltrioleate. Crude extracts of the trehalose lipids were purified using silica gel chromatography. The structure of the two trehalose lipid components (TL A and TL B) was elucidated using a combination of matrix-assisted laser desorption/ionization time-of-flight/time-of-flight/tandem mass spectroscopy (MALDI-ToF-ToF/MS/MS) and multidimensional NMR experiments. The biosurfactants were identified as 1-α-glucopyranosyl-1-α-glucopyranosid carrying two acyl chains varying of C4 to C6 and C16 to C18 at the 2' and 3' carbon atom of one sugar unit. The trehalose lipids produced demonstrate surface-active behavior and emulsifying capacity. Classified as risk group 1 organisms, T. spumae and T. pseudospumae hold potential for the production of environmentally friendly surfactants.


Subject(s)
Actinobacteria/metabolism , Lipid Metabolism , Surface-Active Agents/metabolism , Trehalose/metabolism , Chromatography, Gel , Culture Media/chemistry , Lipids/isolation & purification , Magnetic Resonance Spectroscopy , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Surface-Active Agents/isolation & purification , Tandem Mass Spectrometry , Trehalose/isolation & purification
16.
Nat Prod Res ; 28(19): 1613-8, 2014.
Article in English | MEDLINE | ID: mdl-24967746

ABSTRACT

A phytochemical study of the 95% ethanolic extract of the whole plant of Lancea tibetica Hook. f. et Thoms. led to the isolation of a new trehalose ester, 6-O-undecanoyl-α,ß-trehalose (1), along with 23 known compounds (2-24), of which compounds 2-17 were isolated from this plant for the first time. The structures of these compounds were established on the basis of spectroscopic methods. Compound 1 was evaluated for their in vitro anti-proliferative activities against MCF-7, NCI-H460 and Hep-G2 tumour cell lines. Compound 1 exhibited potent inhibitory activity against NCI-H460 cell growth, in contrast to moderate cytotoxic activity against MCF-7 and Hep-G2 cells.


Subject(s)
Antineoplastic Agents, Phytogenic/isolation & purification , Drugs, Chinese Herbal/isolation & purification , Trehalose/analogs & derivatives , Trehalose/isolation & purification , Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/pharmacology , Cell Proliferation/drug effects , Drug Screening Assays, Antitumor , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/pharmacology , Female , Hep G2 Cells , Humans , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Trehalose/chemistry , Trehalose/pharmacology
17.
J Antibiot (Tokyo) ; 67(4): 319-22, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24448628

ABSTRACT

A new trehalose analog, lentztrehalose [4-O-(2,3-dihydroxy-3-methylbutyl)trehalose], was isolated from an actinomycete Lentzea sp. Lentztrehalose is only weakly hydrolyzed by the trehalose-hydrolyzing enzyme, trehalase, so can be regarded as an enzyme-stable analog of trehalose. Although lentztrehalose does not show apparent toxicity to mammalian cells and microbes, it has antitumor activity in mice bearing S-180 sarcoma and Ehrlich carcinoma cells. In ovariectomized mice, lentztrehalose displayed a bone reinforcement effect in the femur that was superior to trehalose and induced non-morbid suppression of weight gain comparable with trehalose. These results indicate that enzyme-stable analogs of trehalose, such as lentztrehalose, may be more beneficial for human health and thus have potential as substitutes for trehalose as a sweetener.


Subject(s)
Actinobacteria/metabolism , Antineoplastic Agents/therapeutic use , Bone Density Conservation Agents/therapeutic use , Carcinoma, Ehrlich Tumor/drug therapy , Drug Discovery , Osteoporosis, Postmenopausal/prevention & control , Sarcoma 180/drug therapy , Trehalose/analogs & derivatives , Actinobacteria/growth & development , Actinobacteria/ultrastructure , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/isolation & purification , Antineoplastic Agents/metabolism , Bone Density Conservation Agents/chemistry , Bone Density Conservation Agents/isolation & purification , Bone Density Conservation Agents/metabolism , Carcinoma, Ehrlich Tumor/pathology , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Humans , Mice , Mice, Inbred ICR , Molecular Structure , Non-Nutritive Sweeteners/chemistry , Non-Nutritive Sweeteners/isolation & purification , Non-Nutritive Sweeteners/metabolism , Non-Nutritive Sweeteners/therapeutic use , Sarcoma 180/pathology , Substrate Specificity , Survival Analysis , Trehalase/metabolism , Trehalose/chemistry , Trehalose/isolation & purification , Trehalose/metabolism , Trehalose/therapeutic use , Tumor Burden/drug effects , Weight Gain/drug effects
18.
J Antibiot (Tokyo) ; 66(6): 311-7, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23591606

ABSTRACT

Three new natural products, designated trehangelins A, B and C, were isolated by solvent extraction, silica gel and octadecylsilyl silica gel column chromatographies and subsequent preparative HPLC from the cultured broth of an endophytic actinomycete strain, Polymorphospora rubra K07-0510. The trehangelins consisted of a trehalose moiety and two angelic acid moieties. Trehangelins A (IC50 value, 0.1 mg ml(-1)) and C (IC50 value, 0.4 mg ml(-1)), with symmetric structures, showed potent inhibitory activity against hemolysis of red blood cells induced by light-activated pheophorbide a. However, trehangelin B, with an asymmetric structure, displayed only a slight inhibition (IC50 value, 1.0 mg ml(-1)).


Subject(s)
Actinobacteria/chemistry , Biological Products/isolation & purification , Hemolysis/drug effects , Oxidative Stress/drug effects , Biological Products/chemistry , Biological Products/pharmacology , Cell Survival/drug effects , Chemical Phenomena , Chlorophyll/adverse effects , Chlorophyll/analogs & derivatives , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Endophytes/chemistry , Erythrocytes/drug effects , HEK293 Cells , HT29 Cells , Humans , Inhibitory Concentration 50 , Molecular Conformation , Orchidaceae/microbiology , Plant Roots/microbiology , Radiation-Protective Agents/chemistry , Radiation-Protective Agents/isolation & purification , Radiation-Protective Agents/pharmacology , Radiation-Sensitizing Agents/adverse effects , Trehalose/analogs & derivatives , Trehalose/isolation & purification , Trehalose/pharmacology
19.
Biotechnol Prog ; 29(1): 83-90, 2013.
Article in English | MEDLINE | ID: mdl-23172769

ABSTRACT

A dual-enzyme process aiming at facilitating the purification of trehalose from maltose is reported in this study. Enzymatic conversion of maltose to trehalose usually leads to the presence of significant amount of glucose, by-product of the reaction, and unreacted maltose. To facilitate the separation of trehalose from glucose and unreacted maltose, sequential conversion of maltose to glucose and glucose to gluconic acid under the catalysis of glucoamylase and glucose oxidase, respectively, is studied. This study focuses on the hydrolysis of maltose with immobilized glucoamylase on Eupergit® C and CM Sepharose. CM Sepharose exhibited a higher protein adsorption capacity, 49.35 ± 1.43 mg/g, and was thus selected as carrier for the immobilization of glucoamylase. The optimal reaction temperature and reaction pH of the immobilized glucoamylase for maltose hydrolysis were identified as 40°C and 4.0, respectively. Under such conditions, the unreacted maltose in the product stream of trehalose synthase-catalyzed reaction was completely converted to glucose within 35 min, without detectable trehalose degradation. The conversion of maltose to glucose could be maintained at 0.92 even after 80 cycles in repeated-batch operations. It was also demonstrated that glucose thus generated could be readily oxidized into gluconic acid, which can be easily separated from trehalose. We thus believe the proposed process of maltose hydrolysis with immobilized glucoamylase, in conjunction with trehalose synthase-catalyzed isomerization and glucose oxidase-catalyzed oxidation, is promising for the production and purification of trehalose on industrial scales.


Subject(s)
Glucan 1,4-alpha-Glucosidase/metabolism , Glucose Oxidase/metabolism , Glucosyltransferases/metabolism , Trehalose/isolation & purification , Trehalose/metabolism , Biocatalysis , Glucan 1,4-alpha-Glucosidase/chemistry , Glucose Oxidase/chemistry , Hydrolysis , Maltose/chemistry , Maltose/metabolism , Trehalose/chemistry
20.
Carbohydr Res ; 356: 25-36, 2012 Jul 15.
Article in English | MEDLINE | ID: mdl-22486827

ABSTRACT

A variety of trehalose glycolipids have been isolated from natural sources, and several of these glycolipids exhibit important biological properties. These molecules also represent challenging synthetic targets due to their highly amphiphilic character, their large number of functional groups and additional chiral centres. This review highlights some of the recent advances made in the synthesis of trehalose glycolipids, and their associated biological activities.


Subject(s)
Glycolipids/chemistry , Surface-Active Agents/chemistry , Trehalose/chemistry , Animals , Bacteria , Caenorhabditis elegans , Carbohydrate Conformation , Cell Line, Tumor , Cell Survival/drug effects , Cytokines/biosynthesis , Esters , Glycolipids/isolation & purification , Glycolipids/pharmacology , Humans , Macrophages/drug effects , Macrophages/metabolism , Neoplasms/drug therapy , Neoplasms/metabolism , Nitric Oxide/biosynthesis , Surface-Active Agents/isolation & purification , Surface-Active Agents/pharmacology , Trehalose/isolation & purification , Trehalose/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...